Meyka Pro banner
Natera, Inc.

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NTRANASDAQ
HealthcareMedical - Diagnostics & Research
$336.71
$8.99(2.74%)
U.S. Market opens in NaNh NaNm

Natera, Inc. (NTRA)

Meyka AI Score

Z

Key Financials

Market Cap48.2B
P/E Ratio-246.54
EPS (TTM)$-1.32
ROE-0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$329.99
3 Months$303.76
1 Year Target$239.68

NTRA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Natera, Inc. (NASDAQ: NTRA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Natera, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NTRA on the NASDAQ shows an RSI of 71.51, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $239.68 for the NASDAQ listing.

Key metrics behind Natera, Inc.'s NASDAQ-traded stock include a P/E ratio of -246.54 and a market capitalization of 48.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NTRA on the NASDAQ.

Price Performance (NASDAQ: NTRA)

1-Day Change
2.74%
5-Day Change
4.88%
1-Month Change
28.52%
3-Month Change
67.59%
6-Month Change
58.95%
Year-to-Date (YTD) Change
46.98%
1-Year Change
107.24%
3-Year Change
486.81%
5-Year Change
192.36%
All-Time (Max) Change
1770.61%

Contact Information

650 249 9090
13011 McCallen Pass Building A, Austin, TX, 78753

Company Facts

61,380 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions